Morgan Stanley Tarsus Pharmaceuticals, Inc. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,398,918 shares of TARS stock, worth $79.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,398,918
Previous 1,957,688
22.54%
Holding current value
$79.1 Million
Previous $39.6 Million
119.96%
% of portfolio
0.01%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TARS
# of Institutions
166Shares Held
39.5MCall Options Held
190KPut Options Held
92.9K-
Rtw Investments, LP New York, NY3.27MShares$108 Million1.91% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.86MShares$94.4 Million3.9% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$87.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$74.3 Million9.98% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.14MShares$70.5 Million4.48% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $879M
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...